SCHEMBL3036832

SCHEMBL3036832

NC(=O)c1ccc(-c2ccc(C(=O)N(O)c3ccccc3)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.57
KDM4E B2RXH2 2/20 0.57
MKNK1 Q9BUB5 5/20 0.50
MKNK2 Q9HBH9 4/20 0.50
MAPT P10636 2/20 0.50
CYP2C19 P33261 2/20 0.50
HSD17B10 Q99714 2/20 0.50
POLB P06746 1/20 0.50
CYP3A4 P08684 1/20 0.50
PARP1 P09874 1/20 0.50
TSHR P16473 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 2/20 0.45
DHODH Q02127 1/20 0.45
PARP10 Q53GL7 3/20 0.44
PLA2G10 O15496 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23511690 0.91 HPGD (0.66) HPGDKDM4EMAPTTDP1L3MBTL1
SCHEMBL27690326 0.89 HPGD (0.64) HPGDKDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL873994 0.85 HPGD (0.72) HPGDKDM4EMAPTTDP1L3MBTL1
SCHEMBL29083645 0.84 MAPT (0.52) HPGDKDM4EMKNK1MKNK2MAPT
SCHEMBL11270838 0.83 KDM4E (0.65) HPGDKDM4EMAPTCYP2C19HSD17B10
SCHEMBL3029776 0.82 MKNK1 (0.63) MKNK1MKNK2SIRT2CHEK2
SCHEMBL133668 0.81 KDM4E (0.67) HPGDKDM4EMAPTCYP2C19HSD17B10
SCHEMBL11682285 0.79 KDM4E (0.65) HPGDKDM4EMAPTCYP2C19HSD17B10
SCHEMBL28828108 0.79 KDM4E (0.65) HPGDKDM4EMAPTCYP2C19HSD17B10
Ammonia Solution, Strong SCHEMBL11681866 0.79 KDM4E (0.65) HPGDKDM4EMAPTCYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 HPGD 188/4885KDM4E 295/4885MKNK1 3440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.